879093-22-8 Usage
Uses
Used in Organic Synthesis:
N-BOC-4-HYDROXYINDOLE is used as a key intermediate in organic synthesis for the preparation of various complex organic compounds. Its BOC protecting group facilitates controlled reactions, preventing unwanted side reactions and ensuring the desired product formation.
Used in Pharmaceutical Research:
In the pharmaceutical industry, N-BOC-4-HYDROXYINDOLE is used as a starting material for the development of new drugs. Its unique structure and properties make it a promising candidate for the synthesis of bioactive molecules with potential therapeutic applications.
Used in Agrochemical Development:
N-BOC-4-HYDROXYINDOLE is also utilized in the agrochemical sector for the synthesis of new pesticides and other crop protection agents. Its versatile nature allows for the creation of novel compounds with improved efficacy and selectivity.
Used in Material Science:
In the field of material science, N-BOC-4-HYDROXYINDOLE is employed as a building block for the development of new materials with specific properties. Its chemical structure can be modified to create materials with tailored characteristics for various applications, such as sensors, catalysts, or advanced materials for energy storage and conversion.
Check Digit Verification of cas no
The CAS Registry Mumber 879093-22-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,9,0,9 and 3 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 879093-22:
(8*8)+(7*7)+(6*9)+(5*0)+(4*9)+(3*3)+(2*2)+(1*2)=218
218 % 10 = 8
So 879093-22-8 is a valid CAS Registry Number.
879093-22-8Relevant academic research and scientific papers
Structure-Activity Relationship and Biological Investigation of SR18292 (16), a Suppressor of Glucagon-Induced Glucose Production
Cameron, Michael D.,Griffin, Patrick R.,Kamenecka, Theodore M.,Lin, Hua,Lin, Li,Novick, Scott J.,Puigserver, Pere,Ruiz, Claudia,Sharabi, Kfir,Zhu, Di
supporting information, p. 980 - 990 (2021/02/01)
Despite a myriad of available pharmacotherapies for the treatment of type 2 diabetes (T2D), challenges still exist in achieving glycemic control. Several novel glucose-lowering strategies are currently under clinical investigation, highlighting the need f
Nickel-catalyzed removal of alkene protecting group of phenols, alcohols via chain walking process
Meng, Chenkai,Niu, Haolin,Ning, Juehan,Wu, Wengang,Yi, Jun
, (2020/02/04)
An efficient nickel-catalyzed removal of alkene protection group under mild condition with high functional group tolerance through chain walking process has been established. Not only phenolic ethers, but also alcoholic ethers can be tolerated with the retention of stereocenter adjacent to hydroxyl group. The new reaction brings the homoallyl group into a start of new type of protecting group.
NITRONE COMPOUNDS PRODRUGS AND PHARMACEUTICAL COMPOSITIONS OF THE SAME TO TREAT HUMAN DISORDERS
-
Page/Page column 49, (2008/06/13)
Disclosed are aryl, heteroaromatic and bicyclic aryl nitrone compounds and pharmaceutical compositions containing such derivatives. The disclosed compositions are useful for preventing and/or treating pain, neurodegenerative, autoimmune and inflammatory diseases or conditions in mammals.
